Co-treatment of berberine and CP markedly enhanced CP’s cytotoxicity against osteosarcoma MG-63, breast cancer MCF-7, and gastric cancer BGC-823 and SGC-7901 cell lines. The gene discussed is CP; the disease is osteosarcoma.